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A portable epigenetic switch for 
bistable gene expression in bacteria
David R. olivenza1, Hervé nicoloff2, María Antonia Sánchez-Romero1, ignacio cota1,3, 
Dan i. Andersson  2 & Josep casadesús  1
We describe a portable epigenetic switch based on opvAB, a Salmonella enterica operon that undergoes 
bistable expression under DnA methylation control. A DnA fragment containing the opvAB promoter 
and the opvAB upstream regulatory region confers bistability to heterologous genes, yielding off and 
on subpopulations. Bistable expression under opvAB control is reproducible in Escherichia coli, showing 
that the opvAB switch can be functional in a heterologous host. Subpopulations of different sizes can 
be produced at will using engineered opvAB variants. controlled formation of antibiotic-resistant 
and antibiotic-susceptible subpopulations may allow use of the opvAB switch in the study of bacterial 
heteroresistance to antibiotics.
Biosensors able to detect environmental signals are made of a sensor that detects a given input and a reader that 
responds to the input generating a detectable signal in a quantitative or semi-quantitative fashion1. Classical 
sensors employ enzymes or whole cells. Enzyme-based biosensors present the advantage of high selectivity but 
the need for purification can be a drawback due to technical difficulties and high cost. In contrast, whole-cell 
sensors are often easy to use and inexpensive, especially if microbial strains are used2. A common type of micro-
bial biosensor is an engineered strain that responds to physical or chemical inputs generating electrochemical or 
optical signals. Sensors of this type often employ a promoter sensitive to a specific input and a reporter gene that 
produces a detectable signal1,3. The literature contains multiple examples of sensors that detect electrochemical 
and optical signals, and use of fluorescent proteins has become widespread in the last decade4.
An alternative to genetic circuits able to process information in living cells is the design of epigenetic switches. 
This approach has received special attention to develop diagnostic tests for human diseases5–7, while synthetic 
biology based on bacterial epigenetics remains largely unexplored. A relevant exception is the recent development 
of biosensors based on DNA adenine methylation using Escherichia coli as host8.
In this study, we describe the construction and application of an epigenetic switch that drives gene expression 
in a bistable fashion. Bistability generates bacterial subpopulations that differ in a specific phenotypic trait (e. 
g., antibiotic resistance) and have defined sizes. The switch is based on opvAB, a bacterial operon subjected to 
epigenetic control by DNA adenine methylation9–11. Transcription of opvAB is bistable, with concomitant forma-
tion of OpvABOFF and OpvABON cells9. Bistability is controlled by binding of the OxyR transcription factor to a 
regulatory region upstream of the opvAB promoter (Fig. 1A)10. This region contains four sites for OxyR binding 
and four GATC motifs. OpvABOFF and OpvABON cell lineages display alternative patterns of OxyR binding, which 
in turn cause alternative patterns of GATC methylation: in the OFF state, GATC2 and GATC4 are methylated; in 
the ON state, GATC1 and GACT3 are methylated10. Here, we show that a cassette of 689 nucleotides containing 
the opvAB promoter and the upstream regulatory region confers bistability to heterologous genes, and describe 
examples of opvAB-based constructs that produce bacterial subpopulations with distinct phenotypes. One of the 
examples involves formation of an antibiotic-resistant subpopulation upon cloning of an antibiotic resistance 
gene downstream of the opvAB promoter. This construct may provide an experimental system to study bacterial 
heteroresistance (HR) to antibiotics under highly controlled conditions12. HR is a phenotype where a bacterial 
isolate is characterized by the presence of a main susceptible population and a subpopulation with higher anti-
biotic resistance. Increasing evidence suggests that heteroresistance can lead to treatment failure12–17. Yet, little is 
known regarding the characteristics of the heteroresistance phenotypes (i.e. the size of the resistant subpopulation 
or its level of resistance) that are linked to treatment failure. Animal experiments, where infections are started 
with bacterial cultures that carry an antibiotic resistance gene under control of the opvAB switch, would allow 
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Figure 1. Formation of LacOFF and LacON subpopulations under opvAB control. (A) Diagram of the opvAB 
promoter and regulatory region, with the GATC sites outlined. (B) Diagram of the wild type opvAB operon and 
the PopvAB::lacZY construct. (C) Colonies formed on LB + X-gal by a S. enterica strain carrying the lacZY operon 
under the control of the wild type opvAB control region (SV9700, left), and by S. enterica strains carrying the 
lacZY operon under the control of mutant opvAB control regions (SV9701, PopvAB GATC1,2::lacZY::gfp, center; 
SV9702, PopvAB GATC-less::lacZY::gfp, right). (D) Flow cytometry analysis of PopvAB::lacZY expression in strains 
SV9700, SV9701 and SV9702. The sizes of LacON subpopulations are indicated. (E) Growth of strains SV9700, 
SV9701 and SV9702 in NCE-lactose. Error bars represent the standard error of the mean from 3 independent 
replicates. (F) Reversible formation of LacOFF and LacON subpopulations under opvAB control in strain SV9700.
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control of the frequency of the resistant subpopulation and determination of how different ratios of resistant:sus-
ceptible bacteria influence treatment outcome17. Other potential uses of the opvAB switch in synthetic biology 
are discussed.
Results
Bistable expression of lacZY under opvAB transcriptional control. The ability of the opvAB epigenetic 
switch to confer bistable expression to a heterologous locus was tested by engineering a strain that harbored the E. 
coli lacZY operon downstream of the opvAB promoter and its upstream regulatory region (PopvAB - Fig. 1A,B). To 
avoid cell-to-cell heterogeneity associated with variations in plasmid copy number, the construct was engineered in 
the S. enterica chromosome. Construction involved replacement of the opvAB coding region with a promoterless 
lacZY operon, leaving the opvAB promoter and upstream regulatory region intact. The construct harbored the opvA 
ribosome binding site (RBS). Plating of the engineered strain on LB containing X-gal yielded Lac+ (blue) and Lac− 
(white) colonies, thus revealing bistable expression (LacOFF or LacON) of the heterologous lacZY operon (Fig. 1C). 
Streaking of either Lac+ or Lac− colonies on X-gal agar yielded a mixture of Lac+ and Lac− colonies, thus indicating 
the occurrence of reversible bistability (“phase variation”) as previously described for the native opvAB locus9.
Calculation of phase variation frequencies indicated a frequency of 1.1 × 10−4 ± 0.3 per cell and generation 
for the OFF→ON transition, and 3.4 ± 0.1 × 10−2 per cell and generation for the ON→OFF transition. The 
300-fold difference between switching rates was two-fold lower than in the native opvAB locus (OFF → ON, 
6.1 ± 1.7 × 10−5; ON → OFF 3.7 ± 0.1 × 10−2; 600-fold difference between switching rates)9. The increased size of 
the LacON subpopulation may result from multiple factors including potential differences in mRNA stability and 
codon usage constraints.
Variants of the PopvAB::lacZY construct were engineered to further explore the ability of opvAB-driven tran-
scription to confer bistable expression to a heterologous locus. One such variant involved the use of a mutant 
opvAB regulatory region lacking GATC sites 1 and 2 (GATC1,2), previously shown to increase the size of the 
OpvABON subpopulation10. As expected, a higher proportion of Lac+ colonies was detected (Fig. 1C). Another 
variant, used as control, lacked all opvAB GATC sites (GATC-less) and locked lacZY transcription in the ON state 
(Fig. 1C) as previously described for the native opvAB operon9.
Variants carrying a green fluorescent protein gene (gfp) dowstream of the lacZY operon were also engineered, 
and assessment of subpopulation sizes by flow cytometry confirmed that the LacON subpopulation formed by the 
wild type opvAB switch was smaller than that formed by the GATC1,2 variant (Fig. 1D). Furthermore, only cells in 
the LacON state were detected in the strain that harbored the GATC-less construct, and subpopulation formation 
was abolished as above (Fig. 1D).
The ability of the opvAB switch to permit selection of one of the subpopulations was examined by testing the 
ability of strains carrying PopvAB::lacZY::gfp and PopvAB GATC1,2::lacZY::gfp constructs to grow in minimal medium 
with lactose as sole carbon source. As above, a strain carrying the GATC-less PopvAB::lacZY::gfp construct was 
included as a control. Assessment of the growth patterns of these strains revealed that the time required for cul-
ture saturation was dependent on the size of the LacON subpopulation present at the start of the culture (Fig. 1E). 
Reversibility of the LacON state was confirmed by growth on NCE-glucose (Fig. 1F).
Bistable expression of the chimaeric opvAB::lacZY operon in a heterologous host, E. coli. The 
functionality of the opvAB switch in a heterologous host was tested in E. coli. For this purpose, the PopvAB::lacZY::gfp 
construct and its GATC1,2 and GATC-less variants were introduced into the chromosome of E. coli DR3 (ΔlacZY). 
Strains carrying the PopvAB::lacZY-gfp and PopvAB GATC1,2::lacZY::gfp constructs (DR22 and DR23, respectively) 
formed Lac+ and Lac– colonies on X-gal agar, and the number of Lac+ colonies was higher in the strain carrying the 
PopvAB GATC1,2::lacZY::gfp construct. The strain carrying the GATC-less construct (DR24) formed Lac+ colonies 
only (Fig. 2A). Flow cytometry assessment of GFP expression upon growth in LB confirmed the occurrence of 
subpopulations of LacOFF and LacON cells in the strains carrying the PopvAB::lacZY::gfp and PopvAB GATC1,2::lacZY::gfp 
constructs but not in the strain carrying the GATC-less construct (Fig. 2B). As above, growth pattern assessment 
revealed that the time required for culture saturation was dependent on the initial size of the LacON subpopulation 
(Fig. 2C). Altogether, these observations indicated that the opvAB switch is functional in E. coli.
Bistable expression of antibiotic resistance genes under opvAB control. An additional test of 
the ability of the opvAB bistable switch to generate bacterial subpopulations was performed by cloning anti-
biotic resistance genes downstream of the opvAB promoter in the S. enterica chromosome. The antibiotic 
resistance genes chosen for these experiments were aac3-Ib (henceforth, aac3) and aac(6′)-Ib-cr (henceforth, 
aac6), which encode aminoglycoside acetyl transferases18, and blaCTX-M-15 (henceforth, ctxM), which encodes 
an extended-spectrum β-lactamase19. In these constructs, the native ribosome binding sites were replaced with 
a stronger RBS, named BI20 to adjust the sensitivity of the switch to a level that could permit unambiguous 
detection of the antibiotic resistance phenotype under study, thus facilitating discrimination between OFF and 
ON cells. Experiments with strains carrying PopvAB::aac6::gfp and PopvAB::ctxM::gfp fusions (strains SV9703 and 
SV9706, respectively) yielded bacterial subpopulations resistant to kanamycin and to cefotaxime, respectively 
(Fig. 3A). Controls using strains that constitutively expressed aac6 and ctxM (SV9705 and SV9707, respectively) 
showed that the concentrations of antibiotics used permitted growth (Fig. 3A). The wild type strain ATCC 14028 
failed to grow under such conditions, confirming that the concentrations of antibiotics used were bactericidal.
Flow cytometry analysis confirmed that growth in the presence of kanamycin and cefotaxime was a consequence 
of subpopulation selection (Fig. 3B), excluding the idea that growth might result from selection of mutants present in 
the inoculum. This conclusion was further strengthened by the observation that growth in LB restored the initial sizes 
of ON and OFF subpopulations (Fig. 3B).
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Use of the opvAB synthetic switch in generating antibiotic heteroresistance. As a proof of 
concept, we examined the utility of the OpvAB switch to address antibiotic heteroresistance and the question 
of what proportions of resistant subpopulations might lead to clinical treatment failure. Specifically, we tested 
whether the OpvAB switch could generate, in a susceptible main population, defined subpopulations of cells 
with increased antibiotic resistance. For this purpose, we used a S. enterica strain harboring a PopvAB::BI-aac3::gfp 
construct (SV9776). Expression of aac3 (Aac3ON) leads to kanamycin resistance (Kmr). The frequency of Kmr 
cells formed by a pure culture of SV9776 was 1 × 10−2 (Fig. 4A), similar to the frequency of ON cells detected 
when gfp was cloned behind the opvAB promoter (1.1%: Fig. 1D). To obtain smaller subpopulation sizes without 
altering other phenotypic traits of the strain, SV9776 was mixed with an isogenic strain that expressed PopvAB::gfp 
(SV9777) and did not produce any Kmr resistant subpopulation. Mixtures of cells were prepared from overnight 
cultures in Mueller-Hinton (MH) broth at proportions 1:10, 1:100, 1:1,000, 1:10,000 and 0:1. Population analysis 
profile (PAP) tests were then performed by plating on MH agar containing increasing concentrations of kana-
mycin. After overnight incubation, the number of resistant cells and total number of cells were determined to 
allow calculation of the fraction of resistant cells. The numbers of Kmr colonies detected in the PAP tests were 
proportional to the amounts of the Aac3ON subpopulations present in each mixture, and ranged from 1 × 10−2 to 
1 × 10−6 (Fig. 4A). Epsilometer tests (Etests) further confirmed that the size of the Kmr subpopulation decreased 
in a manner proportional to dilution (Fig. 4B).
Discussion
In its native host, the opvAB operon undergoes bistable transcription, which generates OpvABON and OpvABOFF 
subpopulations9. Bistability is reversible (“phase-variable”) and the switching rate is skewed to OFF in the wild 
type9,11. In this study, we show that a 689 bp DNA fragment containing the opvAB promoter and the opvAB 
upstream activating sequence (UAS) confers bistability to genes cloned downstream. For instance, an engineered 
PopvAB::lacZY operon produces LacOFF and LacON subpopulations (Fig. 1C), and addition of a gfp reporter gene 
Figure 2. Formation of LacOFF and LacON subpopulations under opvAB control in E. coli. (A) Left: Colonies 
formed on LB + X-gal by an E. coli strain carrying the lacZY operon under the control of the wild type opvAB 
control region (strain DR22). Center and right: Colonies formed on LB + X-gal by E. coli strains carrying 
the lacZY operon under the control of mutant opvAB control regions (DR23 and DR24). (B) Flow cytometry 
analysis of PopvAB::lacZY expression in strains DR22, DR23 and DR24. The sizes of LacON subpopulations are 
indicated. (C) Growth of strains DR22, DR23 and DR24 in NCE-lactose. Error bars represent the standard error 
of the mean from 3 independent replicates.
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permits discrimination of LacOFF and LacON cells by flow cytometry (Fig. 1D). Utilization of L-lactose sustains 
growth of LacON cells (Fig. 1E), thereby producing increased fluorescence. However, because the opvAB switch is 
reversible, in the absence of L-lactose the system slowly returns to its initial state, with a strong predominance of 
LacOFF cells (Fig. 1F).
The fact that the opvAB cassette is functional in E. coli (Fig. 2) suggests that the switch can be used to generate 
bistability in other heterologous hosts. However, the need of both Dam methylation and OxyR may be an obvious 
limitation. Aside from this caveat, the versatility of the switch is reinforced by an additional example of subpop-
ulation formation presented in Fig. 3: PopvAB-driven bistable expression of kanamycin and cefotaxime resistance 
genes permitted selection of antibiotic-resistant subpopulations in a reversible fashion.
Introduction of mutations in the upstream regulatory region of the native opvAB operon alters the switching 
rate, yielding OpvABON and OpvABOFF subpopulation sizes that are different from those of the wild type10,11. 
Hence, variants of the opvAB switch can be engineered to modulate subpopulation sizes at will. For instance, a 
variant (GATC1,2) that lacks two of the four GATC sites present in the wild type increases the initial size of the 
ON subpopulation (Figs 1 and 2). Additional UAS variants that yield subpopulations of different sizes have been 
described10, and their use may allow choice of other switching frequencies. Modification of the ribosome-binding 
site of genes under PopvAB control can also contribute to adjust the sensitivity of the switch, facilitating detection of 
the phenotype under study. For instance, use of the BI ribosome binding site20 permitted unambiguous detection 
of aac3-mediated kanamycin resistance, thereby facilitating discrimination of Kmr cells (Fig. 4).
As a proof of concept, we have used the opvAB switch to produce antibiotic-resistant and antibiotic-susceptible 
bacterial subpopulations of predetermined sizes. The aim of these experiments was to mimic under laboratory 
conditions bacterial heteroresistance to antibiotics, a phenomenon where small subpopulations of cells show 
higher antibiotic resistance than the main population12. Heteroresistance is difficult to detect and study in clin-
ical samples12, and accurate assessment of the frequencies of subpopulation formation and of their antibiotic 
resistance levels may improve our understanding of heteroresistance as a cause of clinical treatment failure15. 
Experiments shown in Fig. 4 provide evidence that subpopulation formation under opvAB control allows accurate 
modulation of the number of resistant cells present in a population. In principle, the method should be applicable 
to any antibiotic resistance gene. Because we were able to specifically vary the frequency of resistant bacteria in 
Figure 3. (A) Growth of strains SV9703 (PopvAB::aac6::gfp), SV9705 (PopvAB GATC-less::aac6::gfp) SV9706 
(PopvAB::ctxM::gfp) and SV9707 (PopvAB GATC-less::ctxM::gfp) in LB and in LB + antibiotic (kanamycin and 
cefotaxime, respectively). (B) Left: reversibility of formation of Kms and Kmr subpopulations under opvAB 
control. Right: reversibility of formation of CtxMs and CtxMr subpopulations under opvAB control.
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the population, this approach provides a proof of concept to study how different frequencies of resistant subpop-
ulations may affect the outcome of antimicrobial treatment in vivo (e. g., in a murine model). In theory, mixing 
constitutively resistant and susceptible strains that are otherwise isogenic would also lead to bacterial cultures 
with pre-defined amounts of resistant bacteria. However, to reach specific frequencies of resistant bacteria our 
OpvAB-based approach requires mixing bacteria at frequencies 100-fold lower (e. g., to reach frequencies of 
1 × 10−6 Kmr resistant bacteria, the PopvAB::BI-aac3 strain was mixed at a frequency of 1 × 10−4). Thus, an advan-
tage of our opvAB switch-based approach is that it can be expected to be less affected by infection bottlenecks 
that could otherwise eliminate very small subpopulations of bacteria present in the inoculum21. For example, one 
such bottleneck is observed during cecum colonization by Salmonella in mice 2–4 days after oral infection, and is 
dependent on the inflammatory response induced by S. enterica invading epithelial cells22,23.
Additional applications of the opvAB switch can be envisaged, including the design of bistable biosensors. 
For instance, a strain harboring an PopvAB::gfp fusion might be useful to detect bacteriophages in environmental 
samples using flow cytometry24,25, and to identify DNA methylation inhibitors in screens for novel antimicro-
bial drugs26,27. Sensors of this kind can be expected to be selective as growth will occur under specific circum-
stances only. Furthermore, use of fluorescence to monitor growth of ON cells can be expected to be sensitive 
and rapid, and constitutive expression may contribute to robustness, avoiding the problem of instability of 
transcription-based gene circuits28. Besides biosensor design, formation of phenotypic subpopulations under epi-
genetic control might have additional applications in synthetic biology: for instance, division of labour between 
subpopulations performing distinct segments of a catabolic pathway might optimize biodegradation processes29.
Methods
Strains and strain construction. Strains of Salmonella enterica serovar Typhimurium and Escherichia coli 
used in this study are listed in Table 1. Strain construction by targeted gene disruption was achieved using plas-
mids pKD3, pKD4 or pKD13 as templates to generate PCR products for homologous recombination30. Antibiotic 
resistance cassettes introduced during strain construction were excised by recombination with plasmid pCP2030. 
Primers used in strain construction are shown in Table 2. For the construction of translational lac fusions on 
the S. enterica chromosome, FRT sites generated by excision of Kmr cassettes were used to integrate plasmid 
pCE4031. For construction of fluorescent fusions, a DNA fragment containing a promoterless green fluorescent 
protein (gfp) gene and a chloramphenicol resistance cassette was PCR-amplified from plasmid pZEP0732, and the 
resulting PCR product was integrated into the chromosome of each strain. For construction of strains that carry 
antibiotic resistance genes under PopvAB control, a counterselectable cassette containing sacB and ApR genes was 
amplified from strain DA52596 using the oligos opvAB-ampsacB-F and ampsacB-gfp-R. The PCR product was 
integrated into the chromosome of SV6727 and SV6729 respectively, generating the intermediate strains MN441 
Figure 4. The opvAB switch as a tool for the study of antibiotic heteroresistance. (A) Population analysis profile 
(PAP) tests of kanamycin resistance in strains SV9776 and SV9777 (carrying PopvAB::BI-aac3::gfp and PopvAB::gfp 
constructs, respectively). The proportions indicated are those of the mixtures of SV9776:SV9777. Error bars 
represent standard deviations of three independent mixtures. (B) Epsilometer tests (Etests) performed on the 
same mixtures of SV9776 and SV9777. The kanamycin resistant subpopulations appear as low-density lawns 
(mixtures 1:0 and 1:10) or as isolated colonies growing at kanamycin concentrations above the MIC of the main 
susceptible population ([Km] > 1 mg/L - mixtures 1:10 to 1:10,000). No kanamycin resistant subpopulation 
exists for the 0:1 mixture.
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and MN442, respectively. Antibiotic resistance genes were introduced into these strains by targeted gene disrup-
tion30, and transformants in which the ampicillin-sacB cassette had been excised were selected on minimal plates 
containing sucrose.
Transductional crosses using phage P22 HT 105/1 int20133 were used for transfer of chromosomal markers 
between S. enterica strains34. To obtain phage-free isolates, transductants were purified by streaking on green 
plates35. Phage sensitivity was tested by cross-streaking with P22 H5.
Directed construction of point mutations was achieved using the QuikChange® Site-Directed Mutagenesis 
Kit (Stratagene) using the suicide plasmid pDMS19736 and propagated in E. coli CC118 λ pir. Plasmids derived 
from pMDS197 (pIZ2224 and pIZ2234) were transformed into E. coli S17-1 λ pir. The resulting strains were used 
as donors in matings with S. enterica SV9700, selecting tetracycline-resistant transconjugants on minimal plates. 
One transductant from each mating was propagated as strains SV9701 and SV9702.
culture media and growth conditions. Bertani’s lysogeny broth (LB)37 was used as standard liquid 
medium. Solid LB contained agar at 1.5% final concentration. Mueller-Hinton (MH) broth and agar38 was used 
in antibiotic susceptibility tests. Green plates35 contained methyl blue (Sigma-Aldrich) instead of aniline blue. 
The indicador of β-galactosidase activity in plate tests was 5-bromo-4-chloro-3indolyl-β-D-galactopyranoside 
(X-gal; Sigma-Aldrich, 40 mg/L). No-carbon essential (NCE) medium39, supplemented with either glucose (0, 
2%) or lactose (0, 2%), was used as minimal medium. When necessary, antibiotics were added to the culture 
medium at following concentrations: ampicillin (100 mg/L), kanamycin (50 mg/L), chloramphenicol (25 mg/L), 
and cefotaxamine (40 mg/L).
flow cytometry. Bacterial cultures were grown in LB at 37 °C until exponential phase (O.D.600 0.3). Cells 
were then diluted in PBS to a final concentration of approximately 107/ml. Data acquisition and analysis were 
performed using a Cytomics FC500-MPL cytometer (Beckman Coulter). Data were collected for 100 000 events 
per sample, and were analyzed with CXP and FlowJo8.7 software. Data are represented by a dot plot (forward 
scatter [cell size] versus fluorescence intensity.
Growth curves. Plates were incubated at 37 °C with shaking on an automated microplate reader (Synergy 
HTX Multi-Mode Reader, Biotek), and the absorbance at 600 nm for each well was measured every 30 min. Each 
sample was assayed by triplicate. Growth of SV9700, SV9701, SV9703, DR22, DR23 and DR24 strains was moni-
tored in NCE-lactose and NCE-glucose. Growth of SV9704, SV9705, SV9706, SV9707 was monitored in LB broth 
with and without antibiotics.
Strain Genotype
ATCC 14028a Wild type
MG1655b Wild type
CC118 λ pirb phoA20 thi-1 rspE rpoB argE(Am) recA1 (lambda pir)
S17 λ pirb recA pro hsdR RP4-2-Tc::Mu-Km::Tn7 (lambda pir)













DR23b ∆lacZY PopvAB GATC1,2::lacZY::gfp








Table 1. Bacterial strains and plasmids. aS. enterica; bE. coli.
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calculation of phase variation rates. Phase variation rates were estimated as described by Eisenstein40. 
Briefly, a strain harboring a lacZY fusion was plated on LB + X-gal and colonies displaying an ON or OFF pheno-
type after 16 h growth at 37 °C were selected, resuspended in PBS and re-spread on fresh LB + X-gal plates. Phase 
variation frequencies were calculated using the formula (M/N)/g where M is the number of cells that underwent 
phase variation, N the total number of cells, and g the total number of generations that gave rise to the colony.
epsilometer (e) tests of antibiotic resistance. Etest strips were purchased from bioMérieux. Mixtures 
of overnight cultures of bacteria grown in MH broth were diluted 1:25 in phosphate buffered saline (PBS) to reach 
cell densities of 0.5 MacFarland or about 1.5 × 108 CFU/mL. Bacteria were plated onto MH agar plates using ster-
ile cotton swabs dipped in the cell suspensions, and a Etest strip was applied on top. Plates were incubated 18 h at 
37 °C before reading the results and taking pictures.
Population analysis profile (PAP) tests. PAP tests were performed on MH agar plates supplemented 
with increasing amounts of kanamycin (Sigma Aldrich) as described previously15. Five µl of overnight cultures 
in MH broth (containing approx. 3 × 109 cells/ml) and serial dilutions (down to 10−6) were spread on MH plates 
containing no antibiotics (for total CFU determination) or different concentrations of kanamycin. The plates were 
incubated overnight and the colonies were counted. Colony numbers were plotted in a graph to determine if the 
PAP fulfilled the criteria for heteroresistance (at least 8-fold difference in antibiotic concentration between the 
highest non-inhibitory concentration and the highest inhibitory concentration).
To prepare mixtures of resistant and susceptible cells, three isolated colonies of SV9776 (PopvAB::BI-aac3::gfp, 
kanamycin resistant in the ON state) and SV9777 (PopvAB::gfp, always kanamycin susceptible) were grown over-
night in 2 mL MH broth at 37 °C under shaking. Pure cultures of each overnight or three independent sets of 
SV9776:SV9777 mixtures at proportions ranging from 1:10 to 1:10,000 were used for PAP tests.
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